PL2723344T3 - Złożony środek leczniczy zawierający monoterpen - Google Patents
Złożony środek leczniczy zawierający monoterpenInfo
- Publication number
- PL2723344T3 PL2723344T3 PL12756362T PL12756362T PL2723344T3 PL 2723344 T3 PL2723344 T3 PL 2723344T3 PL 12756362 T PL12756362 T PL 12756362T PL 12756362 T PL12756362 T PL 12756362T PL 2723344 T3 PL2723344 T3 PL 2723344T3
- Authority
- PL
- Poland
- Prior art keywords
- monoterpene
- combination therapy
- containing agent
- agent
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102011111111 | 2011-08-19 | ||
EP12756362.5A EP2723344B1 (de) | 2011-08-19 | 2012-08-19 | Monoterpenhaltiges kombinationstherapeutikum |
PCT/EP2012/003523 WO2013026556A1 (de) | 2011-08-19 | 2012-08-19 | Monoterpenhaltiges kombinationstherapeutikum |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2723344T3 true PL2723344T3 (pl) | 2016-03-31 |
Family
ID=46724328
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL12750533T PL2723330T3 (pl) | 2011-08-19 | 2012-08-19 | Lek kombinowany zawierający środek naczynioskurczowy |
PL12756362T PL2723344T3 (pl) | 2011-08-19 | 2012-08-19 | Złożony środek leczniczy zawierający monoterpen |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL12750533T PL2723330T3 (pl) | 2011-08-19 | 2012-08-19 | Lek kombinowany zawierający środek naczynioskurczowy |
Country Status (6)
Country | Link |
---|---|
US (1) | US20140329782A1 (pl) |
EP (4) | EP2723330B1 (pl) |
ES (1) | ES2547682T3 (pl) |
HU (1) | HUE025567T2 (pl) |
PL (2) | PL2723330T3 (pl) |
WO (3) | WO2013026558A2 (pl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012047674A2 (en) * | 2010-09-27 | 2012-04-12 | Microdose Therapeutx, Inc. | Methods and compositions for disease treatment using inhalation |
DE202015106123U1 (de) * | 2015-10-23 | 2016-10-27 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Monoterpenhaltige Zusammensetzung zur Behandlung von Erkrankungen der Nase |
CN111467349B (zh) * | 2020-05-14 | 2021-06-01 | 华熙生物科技股份有限公司 | 人工泪液及其制备方法 |
CN111603478B (zh) * | 2020-06-29 | 2021-07-30 | 华熙生物科技股份有限公司 | 一种鼻腔用组合物 |
WO2022124961A1 (en) * | 2020-12-07 | 2022-06-16 | Jacobsson Bo Christer | A composition comprising a vitamin d and acetylsalicylic acid. |
DE102020134587A1 (de) | 2020-12-22 | 2022-06-23 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mit beschränkter Haftung | 1,8-Cineol enthaltende Zusammensetzung für die therapeutische Verwendung |
CN115192602B (zh) * | 2021-04-14 | 2024-02-02 | 华熙生物科技股份有限公司 | 一种复合益生元及其在调节肠道功能中的应用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19541919C2 (de) * | 1995-11-10 | 1997-11-20 | Klosterfrau Mcm Vetrieb Gmbh | Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden |
WO1998056388A1 (fr) * | 1997-06-10 | 1998-12-17 | New Vision Co., Ltd. | Agents prophylactiques et/ou remedes contenant de la vitamine d pour prevenir et/ou traiter le xerosis conjonctival/corneen |
US6989377B2 (en) * | 1999-12-21 | 2006-01-24 | Wisconsin Alumni Research Foundation | Treating vitamin D responsive diseases |
US6358939B1 (en) * | 1999-12-21 | 2002-03-19 | Northern Lights Pharmaceuticals, Llc | Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
US7718198B2 (en) * | 2001-06-20 | 2010-05-18 | Metaproteomics, Llc | Treatment modalities for autoimmune diseases |
US6861422B2 (en) * | 2003-02-26 | 2005-03-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
DE10356248A1 (de) * | 2003-11-13 | 2005-06-23 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden |
GB0513984D0 (en) * | 2005-07-07 | 2005-08-17 | Teva Pharma | Dosage form |
WO2007039322A1 (en) * | 2005-09-19 | 2007-04-12 | Bioxell Spa | Use of vitamin d3 compounds for the treatment of uveitis |
US20100209536A1 (en) * | 2006-09-26 | 2010-08-19 | The Brigham And Women's Hospital, Inc. | Methods and Kits for Use in the Treatment and Prevention of Diseases or Conditions of the Immune System or Infectious Diseases |
US20090060878A1 (en) * | 2007-09-04 | 2009-03-05 | The Procter & Gamble Company | Oral Compositions, Products And Methods Of Use |
DE102008036725B4 (de) * | 2008-08-07 | 2021-01-28 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Pharmazeutische Zusammensetzung für die nasale Applikation |
EP2647372A1 (de) * | 2008-09-04 | 2013-10-09 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH | Monoterpene für die Behandlung von Atemwegserkrankungen, insbesondere bronchopulmonalen Erkrankungen |
CN101474192A (zh) * | 2009-01-20 | 2009-07-08 | 崔晓廷 | 糠酸氟替卡松药物制剂及制备方法 |
CN101474189A (zh) * | 2009-01-20 | 2009-07-08 | 崔晓廷 | 卤米松药物制剂及制备方法 |
WO2012047674A2 (en) * | 2010-09-27 | 2012-04-12 | Microdose Therapeutx, Inc. | Methods and compositions for disease treatment using inhalation |
WO2012090224A1 (en) * | 2010-12-29 | 2012-07-05 | Nutracryst Therapeutics Private Limited | Novel cocrystals / molecular salts of mesalamine to be used as improved anti-inflammatory drug |
ITMI20121041A1 (it) * | 2012-06-15 | 2013-12-16 | Lga Biotecnologie S R L | Chemioprevenzione del cancro del colon - retto |
-
2012
- 2012-08-19 EP EP12750533.7A patent/EP2723330B1/de active Active
- 2012-08-19 US US14/239,610 patent/US20140329782A1/en not_active Abandoned
- 2012-08-19 EP EP12756362.5A patent/EP2723344B1/de active Active
- 2012-08-19 PL PL12750533T patent/PL2723330T3/pl unknown
- 2012-08-19 ES ES12750533.7T patent/ES2547682T3/es active Active
- 2012-08-19 EP EP12753908.8A patent/EP2731596A2/de not_active Withdrawn
- 2012-08-19 WO PCT/EP2012/003525 patent/WO2013026558A2/de active Application Filing
- 2012-08-19 HU HUE12750533A patent/HUE025567T2/en unknown
- 2012-08-19 WO PCT/EP2012/003523 patent/WO2013026556A1/de active Application Filing
- 2012-08-19 PL PL12756362T patent/PL2723344T3/pl unknown
- 2012-08-19 EP EP20140003528 patent/EP2857008A1/de not_active Withdrawn
- 2012-08-19 WO PCT/EP2012/003524 patent/WO2013026557A1/de unknown
Also Published As
Publication number | Publication date |
---|---|
EP2723330B1 (de) | 2015-07-08 |
EP2731596A2 (de) | 2014-05-21 |
WO2013026556A1 (de) | 2013-02-28 |
EP2723344A1 (de) | 2014-04-30 |
EP2723344B1 (de) | 2015-10-07 |
EP2723330A1 (de) | 2014-04-30 |
HUE025567T2 (en) | 2016-02-29 |
PL2723330T3 (pl) | 2015-12-31 |
ES2547682T3 (es) | 2015-10-08 |
WO2013026558A3 (de) | 2013-04-11 |
EP2857008A1 (de) | 2015-04-08 |
US20140329782A1 (en) | 2014-11-06 |
WO2013026557A1 (de) | 2013-02-28 |
WO2013026558A2 (de) | 2013-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181615T1 (hr) | Terapijsko sredstvo koje izaziva citotoksičnost | |
ZA201305897B (en) | Combination therapy | |
EP2673286A4 (en) | THERAPEUTIC COMPOUNDS | |
GB201212513D0 (en) | Therapeutic agents | |
GB201114212D0 (en) | Therapeutic agents | |
ZA201403090B (en) | Tropicalizing agent | |
GB201106803D0 (en) | Sonodynamic therapy | |
EP2666475A4 (en) | THERAPEUTIC AGENT FOR ALOPECIA | |
ZA201400120B (en) | Combination therapy | |
GB201119401D0 (en) | Therapeutic agents | |
IL227558A0 (en) | A therapeutic agent for tumors | |
PL2489413T3 (pl) | Przyrząd terapeutyczny | |
HK1197178A1 (en) | Combination als therapy als | |
GB201217704D0 (en) | Therapeutic agents | |
ZA201502595B (en) | Therapeutic methods | |
PL2723330T3 (pl) | Lek kombinowany zawierający środek naczynioskurczowy | |
EP2701744A4 (en) | COMBINATION THERAPY | |
EP2787050A4 (en) | LECITHIN-Organogel formers | |
TWI562734B (en) | Sense-improving agent | |
SG11201402226PA (en) | Therapeutic agent for arthrosis | |
EP2764870A4 (en) | MEANS FOR IMPROVED SENSUAL ASSESSMENT | |
GB201114226D0 (en) | Combination therapy | |
GB201115558D0 (en) | Therapeutic agents | |
GB201110614D0 (en) | Therapeutic agents | |
GB201101128D0 (en) | Therapeutic agents |